Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

25.30
Delayed Data
As of Feb 24
 -0.05 / -0.20%
Today’s Change
12.15
Today|||52-Week Range
27.95
+0.20%
Year-to-Date
No recent news for Supernus Pharmaceuticals Inc.

Today’s Trading

Previous close25.35
Today’s open24.95
Day’s range24.95 - 25.55
Volume231,218
Average volume (3 months)505,238
Market cap$1.3B
Dividend yield--
Data as of 4:00pm ET, 02/24/2017

Growth & Valuation

Earnings growth (last year)-12.50%
Earnings growth (this year)+225.00%
Earnings growth (next 5 years)+50.00%
Revenue growth (last year)+18.34%
P/E ratio15.7
Price/Sales4.76
Price/Book10.43

Competitors

 Today’s
change
Today’s
% change
INVAInnoviva Inc-0.04-0.35%
FWPForward Pharma A/S-0.66-2.31%
EBSEmergent BioSolution...+0.17+0.57%
PBYIPuma Biotechnology I...+1.50+4.32%
Data as of 4:02pm ET, 02/24/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$0.26
Annual revenue (last year)$144.4M
Annual profit (last year)$14.0M
Net profit margin9.70%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Secretary &
Director
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs